These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36940208)

  • 1. Virus-like particle-based nanocarriers as an emerging platform for drug delivery.
    Yuan B; Liu Y; Lv M; Sui Y; Hou S; Yang T; Belhadj Z; Zhou Y; Chang N; Ren Y; Sun C
    J Drug Target; 2023 Jun; 31(5):433-455. PubMed ID: 36940208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-based nanocarriers for drug delivery.
    Ma Y; Nolte RJ; Cornelissen JJ
    Adv Drug Deliv Rev; 2012 Jun; 64(9):811-25. PubMed ID: 22285585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-like Particles as Nanocarriers for Intracellular Delivery of Biomolecules and Compounds.
    He J; Yu L; Lin X; Liu X; Zhang Y; Yang F; Deng W
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant and insect virus-like particles: emerging nanoparticles for agricultural pest management.
    Xue Q; Swevers L; Taning CNT
    Pest Manag Sci; 2023 Sep; 79(9):2975-2991. PubMed ID: 37103223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering Virus-like Particles for Antigen and Drug Delivery.
    Hill BD; Zak A; Khera E; Wen F
    Curr Protein Pept Sci; 2018; 19(1):112-127. PubMed ID: 27875963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-like particles for drug delivery: a review of methods and applications.
    Ikwuagwu B; Tullman-Ercek D
    Curr Opin Biotechnol; 2022 Dec; 78():102785. PubMed ID: 36099859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of novel ssRNA bacteriophage virus-like particles from metagenomic sequencing data.
    Liekniņa I; Kalniņš G; Akopjana I; Bogans J; Šišovs M; Jansons J; Rūmnieks J; Tārs K
    J Nanobiotechnology; 2019 May; 17(1):61. PubMed ID: 31084612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications.
    Chung YH; Cai H; Steinmetz NF
    Adv Drug Deliv Rev; 2020; 156():214-235. PubMed ID: 32603813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioengineering of virus-like particles as dynamic nanocarriers for in vivo delivery and targeting to solid tumours.
    Suffian IFBM; Al-Jamal KT
    Adv Drug Deliv Rev; 2022 Jan; 180():114030. PubMed ID: 34736988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface Functionalization of Rod-Shaped Viral Particles for Biomedical Applications.
    Vaidya AJ; Solomon KV
    ACS Appl Bio Mater; 2022 May; 5(5):1980-1989. PubMed ID: 35148077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paramyxovirus-Like Particles as Protein Delivery Vehicles.
    Panthi S; Schmitt PT; Lorenz FJ; Stanfield BA; Schmitt AP
    J Virol; 2021 Sep; 95(20):e0103021. PubMed ID: 34379508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery.
    Srivastava V; Nand KN; Ahmad A; Kumar R
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus as a Nanocarrier for Drug Delivery Redefining Medical Therapeutics - A Status Report.
    Ojha SK; Pattnaik R; Singh PK; Dixit S; Mishra S; Pal S; Kumar S
    Comb Chem High Throughput Screen; 2022; 25(10):1619-1629. PubMed ID: 33342404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Rous sarcoma Virus-like Particles Displaying hCC49 scFv for Specific Targeted Drug Delivery to Human Colon Carcinoma Cells.
    Kato T; Yui M; Deo VK; Park EY
    Pharm Res; 2015 Nov; 32(11):3699-707. PubMed ID: 26047779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel ssRNA phage VLP platform for displaying foreign epitopes by genetic fusion.
    Liekniņa I; Černova D; Rūmnieks J; Tārs K
    Vaccine; 2020 Aug; 38(38):6019-6026. PubMed ID: 32713683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.
    Karimi M; Mirshekari H; Moosavi Basri SM; Bahrami S; Moghoofei M; Hamblin MR
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):45-62. PubMed ID: 26994592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoration of virus-like particles with an enzymatic activity of biomedical interest.
    Cayetano-Cruz M; Coffeen CF; Valadez-García J; Montiel C; Bustos-Jaimes I
    Virus Res; 2018 Aug; 255():1-9. PubMed ID: 29964063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of virus-like particles as vaccines and biological vehicles.
    Yan D; Wei YQ; Guo HC; Sun SQ
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10415-32. PubMed ID: 26454868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailored Viral-like Particles as Drivers of Medical Breakthroughs.
    Travassos R; Martins SA; Fernandes A; Correia JDG; Melo R
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade.
    Sohail M; Guo W; Li Z; Xu H; Zhao F; Chen D; Fu F
    Curr Med Chem; 2021; 28(19):3753-3772. PubMed ID: 33019919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.